Trademark: 88777356
Word
MICRONOID
Status
Dead
Status Code
606
Status Date
Monday, August 28, 2023
Serial Number
88777356
Mark Type
4000
Filing Date
Wednesday, January 29, 2020
Published for Opposition
Tuesday, June 2, 2020
Abandoned Date
Monday, August 28, 2023

Trademark Owner History
Celularity Inc. - Owner At Publication
Celularity, Inc. - Original Applicant

Classifications
5 Cells and biological preparations intended for medical and clinical use, namely, blood, stem cells, umbilical cord cells, umbilical cord blood, and placental allograft tissue; bioengineered cells for use in immunotherapies for cancer and other diseases; human allograft tissue made from human umbilical cords and human placentas intended for subsequent implantation; human amniotic membrane and human chorionic membrane intended for subsequent implantation; human collagen compositions and extracellular matrix compositions intended for subsequent implantation; biological preparations for medical use, namely, for the treatment of cancer and other diseases, namely, auto-immune diseases, inflammatory diseases, Crohn's Disease and Multiple Myeloma; biological products for medical use, namely, placental-derived natural killer cells, and placental-derived cytotoxic T cells with a chimeric antigen receptor (CAR) specific for a cancer or other disease-associated antigen; cells and biological tissue intended for hair restoration, namely, cells and biological preparations derived from blood, stem cells, umbilical cords, umbilical cord blood, and placental tissue; biological tissue intended for use as a wound covering; wound dressings; burn dressings; surgical dressings; pharmaceutical preparations for wounds; and written instructional materials distributed in connection with the aforesaid goods; biological products for medical use, namely, placental-derived cytotoxic T cells with a chimeric antigen receptor (CAR) specific for a cancer or other disease-associated antigen
1 Cells and biological tissue, namely, blood, stem cells, umbilical cords, umbilical cord blood, placental tissue for use in scientific, laboratory and medical research; bioengineered cells for use in scientific, laboratory and medical research; human allograft tissue made from human umbilical cords and human placentas for use in scientific, laboratory and medical research; human amniotic membrane and human chorionic membrane for use in scientific, laboratory and medical research; human collagen and extracellular matrix compositions for use in scientific, laboratory and medical research; biological preparations for use in scientific, laboratory and medical research; biological products for use in scientific, laboratory and medical research, namely, placental-derived natural killer cells
42 Research, development and testing services for others in the fields of genomics, biotechnology and pharmaceuticals; stem cell research services; research, development and testing services in the fields of genomics, biotechnology and pharmaceuticals, namely, collection, testing, processing, preservation, storage and retrieval of cells and biological tissue, namely, blood, stem cells, umbilical cords, umbilical cord blood, and placental tissue; providing website featuring information in the field of medical research relating to banking stem cells and cord blood banking; medical research to find methods to restore the structure and function of damaged or diseased tissues and organs, including wound care, reconstructive medicine, whole organ and tissue regeneration and renewal; medical research regarding emergent cell therapies; medical research regarding allogeneic immunotherapy; providing on-line information, news and commentary in the field of medical research relating to the foregoing

Trademark Events
Aug 28, 2023
Abandonment Notice E-Mailed - No Use Statement Filed
Aug 28, 2023
Abandonment - No Use Statement Filed
Dec 30, 2022
Notice Of Approval Of Extension Request E-Mailed
Dec 29, 2022
Sou Extension 5 Granted
Dec 27, 2022
Sou Extension 5 Filed
Dec 27, 2022
Sou Teas Extension Received
Jun 29, 2022
Notice Of Approval Of Extension Request E-Mailed
Jun 27, 2022
Sou Extension 4 Granted
Jun 27, 2022
Sou Extension 4 Filed
Jun 27, 2022
Sou Teas Extension Received
Jan 1, 2022
Notice Of Approval Of Extension Request E-Mailed
Dec 30, 2021
Sou Extension 3 Granted
Dec 30, 2021
Sou Extension 3 Filed
Dec 30, 2021
Sou Teas Extension Received
Dec 28, 2021
Applicant/Correspondence Changes (Non-Responsive) Entered
Dec 8, 2021
Case Assigned To Intent To Use Paralegal
Nov 16, 2021
Teas Post Publication Amendment Received
Jun 29, 2021
Notice Of Approval Of Extension Request E-Mailed
Jun 25, 2021
Sou Extension 2 Granted
Jun 25, 2021
Sou Extension 2 Filed
Jun 25, 2021
Sou Teas Extension Received
Dec 31, 2020
Notice Of Approval Of Extension Request E-Mailed
Dec 29, 2020
Sou Extension 1 Granted
Dec 29, 2020
Sou Extension 1 Filed
Dec 29, 2020
Sou Teas Extension Received
Oct 8, 2020
Applicant/Correspondence Changes (Non-Responsive) Entered
Oct 8, 2020
Teas Change Of Correspondence Received
Oct 8, 2020
Teas Change Of Owner Address Received
Jul 28, 2020
Noa E-Mailed - Sou Required From Applicant
Jun 2, 2020
Official Gazette Publication Confirmation E-Mailed
Jun 2, 2020
Published For Opposition
May 13, 2020
Notification Of Notice Of Publication E-Mailed
Apr 27, 2020
Approved For Pub - Principal Register
Apr 17, 2020
Assigned To Examiner
Feb 4, 2020
New Application Office Supplied Data Entered
Feb 1, 2020
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24